Skip to main content
OpenTrials
Completed

NCT Number: NCT02591342

Comparison of a Cemented, Polished Tapered Stem and an Anatomic Stem for Femoral Neck Fracture

Postoperative periprosthetic femoral fracture after hip arthroplasty is associated with considerable morbidity and mortality. Recent cohort studies have demonstrated a high incidence of PPF in elderly patients treated with two commonly used polished, tapered, collarless stems in elderly patients. The aim of this study was to compare the rate and characteristics of PPF in a consecutive cohort of patients treated either the polished tapered CTP stem or the matte anatomic SP2 stem in an elderly population above 80 years of age with femoral neck fracture.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Displaced femoral neck fracture
  • Treated with a primary hip arthroplasty

Exclusion criteria

  • Secondary arthroplasty due to sequel after femoral fracture

Treatment and study plan

Primary outcomes

  1. Incidence of periprosthetic femoral fracture

    Time frame: 2 years

Secondary outcomes

  1. Type of periprosthetic femoral fracture

    Time frame: 2 years

  2. Type of complications after surgery for periprosthetic femoral fracture

    Time frame: 2 years

  3. Mortality

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Sundsvall Hospital

Other

Registry information

Important dates

Study start
2009
Primary completion
2015
Study completion
2015
First posted
Oct 29, 2015
Registry last updated
May 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.